Genesis Drug Discovery & Development appointed Olesia Buiakova, M.D., Ph.D., as chief scientific officer.

BBK Worldwide – for 35 years on the crest of the wave with regard to the development and evolution of the patient recruitment industry – announced its new marketplace position as The Patient Experience Company.

Growth in fibromyalgia drug research over the past five years has made site selection a far less taxing prospect. There are now hundreds of sites capable of performing this research, and the challenge is to gather current feedback on them.

The biopharma industry is perceived to be at a turning point, where companies have the opportunity to meaningfully adapt their innovation strategy and take advantage of major technological advances and new therapeutic modalities.

CRO giant Pharmaceutical Product Development LLC terminated a number of employees in its human resources department, but has provided few details about the job cuts, according to reports.

While acknowledging the many complexities of product development, sponsor teams should factor in these six guiding principles when planning programs for regulatory submission.

It’s a challenge to find and select the right consultants for a clinical study or drug trial.

China, already a global powerhouse in high-tech areas from solar panels to bullet trains, is turning its industrial might to the challenge of making more of its own drugs for a vast and aging population.   Given the 10 years or more it typically takes to bring a new medicine to market, original “Made in […]

Media Alert: Webinar on Improving Clinical Trial Performance – October 2015   WHAT: CRO Analytics will host an upcoming webinar in October, “QPIs: What They Are And How They Drive Your KPIs”. This webinar will review the key concepts surrounding clinical trial metrics malpractice, performance measurement, and Quality Performance Indicators (QPIs); all topics put forth […]

The U.S. Food and Drug Administration (FDA) and the World Health Organisation have intensified investigations into India’s clinical research firms, industry officials said, after recent probes revealed two leading firms had violated standards. The scrutiny is likely to further hurt India’s reputation as a global pharmaceutical hub, as it follows sanctions imposed by the FDA […]